Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Part of paid clinical trials in San Diego, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT05964504
- Status
- Recruiting
Conditions
- Lobular Breast Carcinoma
- Metastatic Breast Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Blood Specimen — PROCEDUREBlood will be drawn via venipuncture
Study Details
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.
Key Dates
- Start date
- Dec 20, 2023
- Status verified
- Mar 2026
- Primary completion
- Feb 28, 2036
- Completion
- Feb 28, 2036
Study Design
- Enrollment
- 12 participants (estimated)
Arms
- Arm: Initial CohortUp to 12 participants at each evaluation timepoint (approximately every 3-6 months to follow standard of care visits) will have up to 40 mL of blood drawn and distributed into 8 cell-free DNA Streck tubes, for plasma isolation, cell free DNA extraction, and ctDNA analysis. Blood for ctDNA analysis will be collected within +/- 14 days of whole body imaging studies which will occur when patients are scheduled for standard of care whole body imaging.
Primary Outcome Measure
Feasibility of registry [ Time Frame: Up to 2 years ]
Central Contacts
- Astrid Quirarte415-476-8390
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Diego | San Diego | California | 92053 | Rebecca Shatsky, MD (PRINCIPAL_INVESTIGATOR) |
| University of California, San Francisco | San Francisco | California | 94122 | Rita Mukhtar, MD (PRINCIPAL_INVESTIGATOR) A. Jo Chien, MD (PRINCIPAL_INVESTIGATOR) |
| Abramson Cancer Center | Philadelphia | Pennsylvania | 19104 | Rachel Jankowitz, MD (PRINCIPAL_INVESTIGATOR) |
| MD Anderson Cancer Center | Houston | Texas | 77030 | Jason Mouabbi, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Diego, CA
By condition
By specialty
Related Studies
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerPHASE1/PHASE2 · Recruiting · Hoffmann-La Roche · Duarte, California
- Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of DiseasePHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · San Carlos, California
- Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)PHASE1 · Recruiting · Minerva Biotechnologies Corporation · Duarte, California
- Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast CancerPHASE1/PHASE2 · Recruiting · Phoenix Molecular Designs · Gilbert, Arizona